DC6: Kian Stenbolt | NKUA

Principal Investigator: Christina Dalla
DC5: Lasse Damgaard | SU

Principal Investigator: Pehr Granqvist
DC4: Holly Hepburn | UMCG

Principal Investigator: Joost Breeksema
DC3: Marcelo Tisoc Mora | NIMH

Principal Investigator: Tomás Palenicek
DC2: Max Neuhaus | UU

Principal Investigator: Maria Lindskog
DC1: Nina Boulens | UMCG

Principal Investigator: Jens van Dalfsen
DC15 – Evaluating the impact of controlled self-experience with psychedelics in therapist training. A clinical trial.
Doctoral Candidate DC15: Charlotte Schiewe | UB Description For this project, the doctoral candidate will be involved in a clinical trial investigating the impact of controlled personal experiences with psychedelics in physicians and psychotherapists within a therapist training context. The study examines the subjective risks and benefits of personal psychedelic experiences in this professional population, […]
DC16 – Clinical development of psychedelic-assisted therapy: transdiagnostic mechanisms and contextual factors
Doctoral Candidate DC16: Aline Frick | UZH Description Psychedelic therapies (PT) are emerging as a promising treatment paradigm across a range of mental health conditions. While early clinical studies demonstrate encouraging efficacy, there remains a need to better understand transdiagnostic mechanisms of therapeutic change and to systematically investigate contextual factors such as set and setting, […]
DC14 – Harmonising Ethical Regulation of Psychedelic Therapy with Broader Medical Practices
Doctoral Candidate DC14: Julia Etkin | Charité Description In addition to questions on clinical efficacy and safety of psychedelic therapy, ethical concerns have been raised both in clinical trials and (limited) pre-approval access programs. Ethical aspects will be crucial in the further research and implementation of psychedelic therapy. The objective of this project is to […]
DC13 – Identifying ethical, legal and societal challenges and opportunities for applying psychedelic therapy
Doctoral Candidate DC13: Sofia Vanzan | UG Description Psychedelic therapy has the potential to revolutionize mental disorder treatments. Yet it also raises questions about the position of the patients who are (potentially) undergoing the treatment, especially when considered in light of their human right to mental health as recognised in international human rights law. Questions […]